HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

congenital pulmonary Lymphangiectasia

A hereditary form of lymphangiectasis that affects the lungs and is frequently lethal in utero. It is characterized by chronic pleural effusions, pachypleuritis, pleural membrane thickenings, EDEMA; HYDROPS FETALIS, growth retardation, and recurrent RESPIRATORY INFECTIONS. OMIM: 265300
Also Known As:
Lymphangiectasia, pulmonary, congenital; Lymphangiectasia pulmonary congenital; Lymphangiomatosis, pulmonary; Pulmonary cystic lymphangiectasis
Networked: 5 relevant articles (0 outcomes, 0 trials/studies)

Disease Context: Research Results

Experts

1. Malleske, D T: 1 article (05/2015)
2. Yoder, B A: 1 article (05/2015)
3. Enlow, E: 1 article (09/2014)
4. French, H M: 1 article (09/2014)
5. Gray, M: 1 article (09/2014)
6. Itkin, M: 1 article (09/2014)
7. Keller, M S: 1 article (09/2014)
8. Kovatis, K Z: 1 article (09/2014)
9. Stuart, T: 1 article (09/2014)
10. Hwang, Joon Ho: 1 article (04/2014)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to congenital pulmonary Lymphangiectasia:
1. Octreotide (Sandostatin)FDA LinkGeneric
2. Ethiodized Oil (Ethiodol)FDA Link
3. Sildenafil Citrate (Viagra)FDA Link

Therapies and Procedures

1. Therapeutics
2. Pneumonectomy (Lung Volume Reduction)
3. Critical Care (Surgical Intensive Care)